Observational Study Assessing for Effect of CREON on Symptoms of Exocrine Pancreatic Insufficiency (EPI) in Patients With EPI Due to Chronic Pancreatitis (CP)
Latest Information Update: 01 Apr 2024
At a glance
- Drugs Pancrelipase (Primary)
- Indications Exocrine pancreatic insufficiency
- Focus Therapeutic Use
- Acronyms CisCP
- Sponsors AbbVie
- 27 Mar 2024 Status changed from active, no longer recruiting to completed.
- 28 Feb 2024 Status changed from recruiting to active, no longer recruiting.
- 26 Jun 2023 Planned End Date changed from 30 Jun 2023 to 31 Mar 2024.